Skip to content
DraconiticResearch
Search Sources API
190,860 studies31 sourcesUpdated 53 min ago
Peer-reviewedCC BYMedical sciences (Basel, Switzerland)

APRI and FIB-4 for Liver Fibrosis Assessment in Chronic Hepatitis B: Evidence from a Hyperendemic Andean Setting

4 affiliations
  1. 1Escuela Profesional de Medicina Humana, Facultad de Ciencias de la Salud, Universidad Nacional de San Cristóbal de Huamanga, Ayacucho 05001, Peru; (C.C.C.V.); (E.Y.H.H.)
  2. 2Programa Académico de Microbiología, Facultad de Ciencias Biológicas, Universidad Nacional de San Cristóbal de Huamanga, Ayacucho 05001, Peru;
  3. 3Departamento Académico de Microbiología Médica, Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima 09001, Peru;
  4. 4Pathogen Genetics Research Group (PATHO-GEN), Organization for Medical Innovation and Collaboration for Sciences (OMICS), Lima 15072, Peru;

Related

  1. Preliminary evidence that non-fasting serum asprosin differs by sex but not by fibrosis stage in chronic hepatitis C
    Georg Peschel, Kilian Weigand, Martina Müller +1
    Egyptian Liver JournalPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  2. A Multidimensional Assessment of Cardiometabolic Risk in Asian Americans with Chronic Hepatitis B Using the All of Us Datasets
    Lin Zhu, Amanda C. Yang, Han Le +8
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Development and internal validation of a CatBoost-SHAP-guided nomogram for significant liver fibrosis in children with chronic hepatitis B.
    Yuanzhen Zhang, Tingting Wu, Yunan Chang +9
    Frontiers in medicinePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  4. Could Dirofilaria immitis contribute to occult allergic sensitization? Serological evidence from allergic patients in a hyperendemic area
    José Alberto Montoya-Alonso, Alfonso Balmori-de la Puente, Iván Rodríguez-Escolar +4
    Frontiers in allergyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Value-based price corridor for bepirovirsen in chronic hepatitis B: an early health technology assessment in a cost-compressed setting.
    Kaijie Yao, Mengxia Yan, Yun Bao +3
    Health economics reviewPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCDOAJ
BibTeX
@article{vargas2026apri,
  title = {{APRI and FIB-4 for Liver Fibrosis Assessment in Chronic Hepatitis B: Evidence from a Hyperendemic Andean Setting}},
  author = {Carol Celeste Cordero Vargas and Evy Yamil Huaman Huallanca and Homero Ango-Aguilar and Obert Marín-Sánchez and Ruy D. Chacón and Jimmy H. Ango-Bedriñana},
  journal = {Medical sciences (Basel, Switzerland)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13707272},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - APRI and FIB-4 for Liver Fibrosis Assessment in Chronic Hepatitis B: Evidence from a Hyperendemic Andean Setting
AU  - Carol Celeste Cordero Vargas
AU  - Evy Yamil Huaman Huallanca
AU  - Homero Ango-Aguilar
AU  - Obert Marín-Sánchez
AU  - Ruy D. Chacón
AU  - Jimmy H. Ango-Bedriñana
PY  - 2026
DA  - 2026/10/01
JO  - Medical sciences (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13707272
SN  - 2076-3271
ER  -